Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06140134 · ClinicalTrials.gov registry record
Liver Transplantation in Intrahepatic Cholangiocarcinoma
A clinical trial of Intrahepatic Cholangiocarcinoma and Cholangiocarcinoma, Intrahepatic, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- 30
- Enrollment target
- 2
- Study locations
NCT06140134 is a study of Intrahepatic Cholangiocarcinoma and Cholangiocarcinoma, Intrahepatic that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 30 participants, below the 134-participant average among 17 other Intrahepatic Cholangiocarcinoma trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06140134, a study of Intrahepatic Cholangiocarcinoma and Cholangiocarcinoma, Intrahepatic, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of the current study is to determine the potential efficacy of liver transplantation in the form of patients' overall survival (OS) after neoadjuvant systemic therapy in patients with biologically responsive locally advanced non-metastatic intrahepatic cholangiocarcinoma (iCCA) in comparison to patients historically treated with chemotherapy alone.
Conditions Studied
Interventions
- PROCEDURE Liver Transplant
Study Locations (2)
New Jersey
- Rutgers New Jersey Medical School - Newark
- University Hospital - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-12-15 |
| Est. Completion | 2029-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06140134
The ClinicalTrials.gov registry entry for NCT06140134 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 134-participant average among 17 other Intrahepatic Cholangiocarcinoma trials with a reported enrollment target (78% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Intrahepatic Cholangiocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Liver Transplant is the first listed.
NCT06140134 reports 2 study locations spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06140134 about?
NCT06140134 is a clinical study titled "Liver Transplantation in Intrahepatic Cholangiocarcinoma". The aim of the current study is to determine the potential efficacy of liver transplantation in the form of patients' overall survival (OS) after neoadjuvant systemic therapy in patients with biologically responsive locally advanced non-metastatic intrahepatic cholangiocarcinoma (iCCA) in comparison...
What is the current status of trial NCT06140134?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-12-15. Estimated completion is 2029-11.
What conditions does trial NCT06140134 study?
This clinical trial studies the following conditions: Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma, Intrahepatic.
What interventions are being tested in trial NCT06140134?
The interventions under investigation include: Liver Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT06140134?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06140134 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intrahepatic Cholangiocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
RECRUITING
-
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
RECRUITING · Phase 1
-
The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer
RECRUITING · Phase 2
-
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
RECRUITING · Phase 2
-
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
RECRUITING · Phase 2
-
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
RECRUITING · Phase 1
Explore more on PlainTrial
Intrahepatic Cholangiocarcinoma
All registered trials for this condition
Cholangiocarcinoma, Intrahepatic
All registered trials for this condition
New Jersey
All trials with a study site in New Jersey
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.